Screener
GeneDx Holdings WGS Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Total liabilities | 252,177 | 215,528 |
| Purchase commitments and contingencies (Note 9) | ||
| Stockholders’ Equity: | ||
| Preferred Stock, $0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Class A common stock, $0.0001 par value: 1,000,000,000 shares authorized, 29,666,318 and 29,245,296 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 3 | 3 |
| Additional paid-in capital | 1,690,249 | 1,680,738 |
| Accumulated deficit | (1,436,811) | (1,373,495) |
| Accumulated other comprehensive income | 683 | 936 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's preferred stock, shares authorized?
- GeneDx Holdings (WGS) reported preferred stock, shares authorized of $1M in Q1 2026.
- How has GeneDx Holdings's preferred stock, shares authorized changed year-over-year?
- GeneDx Holdings's preferred stock, shares authorized decreased by 0.0% year-over-year, from $1M to $1M.
Ask your AI about GeneDx Holdings's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude